Brought to you by 
Ono & SmithKline cross-license asthma & prostate products
13 Jul 1999
Executive Summary
Ono Pharmaceutical and SmithKline Beecham have signed option agreements to cross-license two products; they expect to exercise their options later in 1993. Ono's exclusive rights will cover Japan, S. Korea and Taiwan; SKB gets all other markets.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Product or Technology Swap
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com